INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Open-market sale · 10b5-1 plan
SELL$204K
2,000 sh
Dec 23, 2025
Page 1607 of 1855
← PrevNext →
Dec 29, 2025
traded Dec 23, 2025
+6d
SEC Form 4

Evidence

14
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Option exercise
M$59K
24.0K sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

13
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Dec 29, 2025Dec 29, 2025
traded Dec 29, 2025
+0dSEC Form 4

Evidence

12
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Gift
G—
450 sh
Dec 29, 2025Dec 29, 2025
traded Dec 29, 2025
+0dSEC Form 4

Evidence

12
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Dec 29, 2025Dec 29, 2025
traded Dec 29, 2025
+0dSEC Form 4

Evidence

12
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$134K
15.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

12
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Dec 29, 2025Dec 29, 2025
traded Dec 29, 2025
+0dSEC Form 4

Evidence

11
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Option exercise
M—
37.5K sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

11
IA
Imberman AlanCFO and Treasurer
WLTHWEALTHFRONT CORP
Option exercise
M—
3,015 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

11
IA
Imberman AlanCFO and Treasurer
WLTHWEALTHFRONT CORP
Option exercise
M—
15.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

11
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Derivative conversion · 10b5-1 plan
C—
800.0K sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

11
IA
Imberman AlanCFO and Treasurer
WLTHWEALTHFRONT CORP
Option exercise
M—
37.5K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

11
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Option exercise
M—
24.0K sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

11
IA
Imberman AlanCFO and Treasurer
WLTHWEALTHFRONT CORP
Option exercise
M$8,774
3,015 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

11
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion
C—
150.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

10
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$761K
45.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

10
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
12.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

9
JN
Jones NonaDirector
GLOOGloo Holdings, Inc.
Grant or award
A—
7,500 sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

9
SJ
Scheiwer Mark JEVP, CFO & CAO
SMGSCOTTS MIRACLE-GRO CO
Grant or award
A$569
10 sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$138
21 sh
Dec 25, 2025Dec 29, 2025
traded Dec 25, 2025
+4dSEC Form 4

Evidence

9
SE
Seamon Paul E.Chief Financial Officer
GLOOGloo Holdings, Inc.
Grant or award
A—
116.7K sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

9
GR
Gruenewald RobertDirector
GLOOGloo Holdings, Inc.
Grant or award
A—
138.9K sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

8
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$26K
25.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

8
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$26K
25.0K sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

7
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$107K
20.8K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

7
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$104K
20.8K sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

7
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
20.8K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$4,389
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$8,580
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
2,194 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$19K
2,194 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
SS
Skates SpenserDirector, Chief Executive Officer, 10% Owner
AMPLAmplitude, Inc.
Derivative conversion · 10b5-1 plan
C—
42.7K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

5
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$1,775
59 sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$761K
45.0K sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$740K
45.0K sh
Dec 29, 2025Dec 29, 2025
traded Dec 29, 2025
+0dSEC Form 4

Evidence

4
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$6,849
30.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence